[Clinical examination of Dolo-Tensilan in gynecology].
D000588:Amines / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use*; D000983:Antipyrine / Q000627:therapeutic use*; D004412:Dysmenorrhea / Q000188:drug therapy; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy*; D006801:Humans; D010146:Pain / Q000188:drug therapy; D010276:Parasympatholytics / Q000627:therapeutic use*; D010640:Phenothiazines / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use; D011181:Postnatal Care; D011183:Postoperative Complications; D011413:Propantheline / Q000627:therapeutic use; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*; D013035:Spasm / Q000188:drug therapy; D014966:Xanthenes / Q000627:therapeutic use*
D000588:Amines; D000700:Analgesics; D010276:Parasympatholytics; D010640:Phenothiazines; D010879:Piperazines; D000644:Quaternary Ammonium Compounds; D014966:Xanthenes; D011413:Propantheline; D000983:Antipyrine
Klinische Prüfung von Dolo-Tensilan in der Frauenheilkunde.